🚀 VC round data is live in beta, check it out!
TchaikaPharma Valuation Multiples
Discover revenue and EBITDA valuation multiples for TchaikaPharma and similar public comparables like Sanofi India, Ventyx Biosciences, Mega Lifesciences, Compass Therapeutics and more.
TchaikaPharma Overview
About TchaikaPharma
Tchaikapharma Highquality Medicines AD is engaged in the business of manufacturing and selling pharmaceuticals in Bulgaria. The company specializes in both generic and in-licensed manufacturing. The company has medicines for Anaesthetics, Nervous system, Oncology, Anti-Inflammatory and Anti-Rheumatic, Antibiotics, Digestive system, diabetes and metabolism, and Respiratory system. The company generates all of its revenue from the sale of medicines. Geographically, the company generates the majority of its revenue from Bulgaria.
Founded
2000
HQ
Employees
207
Website
Sectors
Financials (FY)
EV
$1B
TchaikaPharma Financials
TchaikaPharma reported last fiscal year revenue of $39M and EBITDA of $6M.
In the same fiscal year, TchaikaPharma generated $13M in gross profit, $6M in EBITDA, and $4M in net income.
TchaikaPharma P&L
In the most recent fiscal year, TchaikaPharma reported revenue of $39M and EBITDA of $6M.
TchaikaPharma expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $39M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $13M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 33% | XXX | XXX | XXX |
| EBITDA | — | XXX | $6M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 16% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 12% | XXX | XXX | XXX |
| Net Profit | — | XXX | $4M | XXX | XXX | XXX |
| Net Margin | — | XXX | 10% | XXX | XXX | XXX |
| Net Debt | — | — | $5M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
TchaikaPharma Stock Performance
TchaikaPharma has current market cap of $1B, and enterprise value of $1B.
Market Cap Evolution
TchaikaPharma's stock price is $10.60.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $1B | -0.7% | XXX | XXX | XXX | $0.04 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialTchaikaPharma Valuation Multiples
TchaikaPharma trades at 26.5x EV/Revenue multiple, and 162.7x EV/EBITDA.
TchaikaPharma Financial Valuation Multiples
As of March 21, 2026, TchaikaPharma has market cap of $1B and EV of $1B.
Equity research analysts estimate TchaikaPharma's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
TchaikaPharma has a P/E ratio of 262.0x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 26.5x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 162.7x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 220.0x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 79.9x | XXX | XXX | XXX |
| P/E | — | XXX | 262.0x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 473.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified TchaikaPharma Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
TchaikaPharma Margins & Growth Rates
TchaikaPharma's revenue in the last fiscal year grew by 20%.
TchaikaPharma Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 20% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 16% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 28% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 21% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
TchaikaPharma Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Sanofi India | XXX | XXX | XXX | XXX | XXX | XXX |
| Ventyx Biosciences | XXX | XXX | XXX | XXX | XXX | XXX |
| Mega Lifesciences | XXX | XXX | XXX | XXX | XXX | XXX |
| Compass Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SSY Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
TchaikaPharma M&A Activity
TchaikaPharma acquired XXX companies to date.
Last acquisition by TchaikaPharma was on XXXXXXXX, XXXXX. TchaikaPharma acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by TchaikaPharma
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialTchaikaPharma Investment Activity
TchaikaPharma invested in XXX companies to date.
TchaikaPharma made its latest investment on XXXXXXXX, XXXXX. TchaikaPharma invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by TchaikaPharma
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout TchaikaPharma
| When was TchaikaPharma founded? | TchaikaPharma was founded in 2000. |
| Where is TchaikaPharma headquartered? | TchaikaPharma is headquartered in Bulgaria. |
| How many employees does TchaikaPharma have? | As of today, TchaikaPharma has over 207 employees. |
| Is TchaikaPharma publicly listed? | Yes, TchaikaPharma is a public company listed on Bulgarian Stock Exchange. |
| What is the stock symbol of TchaikaPharma? | TchaikaPharma trades under THQM ticker. |
| When did TchaikaPharma go public? | TchaikaPharma went public in 2012. |
| Who are competitors of TchaikaPharma? | TchaikaPharma main competitors are Sanofi India, Ventyx Biosciences, Mega Lifesciences, Compass Therapeutics. |
| What is the current market cap of TchaikaPharma? | TchaikaPharma's current market cap is $1B. |
| What is the current revenue of TchaikaPharma? | TchaikaPharma's last fiscal year revenue is $39M. |
| What is the current EV/Revenue multiple of TchaikaPharma? | Current revenue multiple of TchaikaPharma is 26.5x. |
| Is TchaikaPharma profitable? | No, TchaikaPharma is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.